Center for Cardiovascular Science, The Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, UK; Department of Pediatrics, Hamamatsu University School of Medicine, Hamamatsu, Japan; Department of Pediatrics, Teine-Keijinkai Hospital, Sapporo, Japan.
Center for Cardiovascular Science, The Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, UK; Division of Developmental Biology, The Roslin Institute, The University of Edinburgh, Edinburgh, UK.
J Pediatr. 2020 May;220:249-253. doi: 10.1016/j.jpeds.2019.12.054. Epub 2020 Jan 24.
There are few biomarkers to predict efficacy of glucocorticoid treatment in childhood acute lymphoblastic leukemia (ALL) at diagnosis. Here, we demonstrate reciprocal regulation of 11beta-hydroxysteroid dehydrogenase (11β-HSD), may predict the apoptotic response of ALL to glucocorticoid treatment. Our data may be useful to refine glucocorticoid treatment, to retain benefit while minimizing side effects.
目前几乎没有生物标志物可以预测儿童急性淋巴细胞白血病(ALL)在诊断时对糖皮质激素治疗的疗效。在这里,我们证明了 11β-羟类固醇脱氢酶(11β-HSD)的相互调节可能预测 ALL 对糖皮质激素治疗的凋亡反应。我们的数据可能有助于完善糖皮质激素治疗方案,在最小化副作用的同时保留疗效。